ATP13A2 antibody (AA 67-210)

Catalog No. ABIN6137296

Product Details anti-ATP13A2 Antibody

Target: ATP13A2 (ATPase Type 13A2 (ATP13A2))

Binding Specificity: AA 67-210

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This ATP13A2 antibody is un-conjugated

Application: Western Blotting (WB)

Sequence: WKPLWGVRLR LRPCNLAHAE TLVIEIRDKE DSSWQLFTVQ VQTEAIGEGS LEPSPQSQAE DGRSQAAVGA VPEGAWKDTA QLHKSEEAKR VLRYYLFQGQ RYIWIETQQA FYQVSLLDHG RSCDDVHRSR HGLSLQDQMV RKAI

Cross-Reactivity: Human, Mouse, Rat

Characteristics: Polyclonal Antibodies

Purification: Affinity purification

Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 67-210 of human ATP13A2 (NP_001135446.1).

Isotype: IgG

Application Details

Application Notes: WB,1:500 - 1:2000

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C. Avoid freeze / thaw cycles.

Target Details for ATP13A2

Target: ATP13A2 (ATPase Type 13A2 (ATP13A2))

Alternative Name: ATP13A2 (ATP13A2 Products)

Background: This gene encodes a member of the P5 subfamily of ATPases which transports inorganic cations as well as other substrates. Mutations in this gene are associated with Kufor-Rakeb syndrome (KRS), also referred to as Parkinson disease 9. Multiple transcript variants encoding different isoforms have been found for this gene.,ATP13A2,CLN12,HSA9947,KRPPD,PARK9,SPG78,Cancer,Signal Transduction,Endocrine & Metabolism,Neuroscience,Neurodegenerative Diseases,Dopamine Signaling in Parkinson's Disease,ATP13A2

Molecular Weight: 125 kDa/128 kDa

Gene ID: 23400

UniProt: Q9NQ11

Pathways: Ribonucleoside Biosynthetic Process